Singapore, May 12 -- The Australian CRO, Avance Clinical, said there was a 34% increase in the number of international trials registered in Australia and New Zealand in the past month compared with the previous month, as both countries are among the first globally to emerge from the COVID-19 crisis. (ClincialTrials.Gov)

Register for the Biospectrum Asia and Avance Clinical Webinar here. https://biospectrumasia.com/avance-webinar

Community and business rules are changing as Australia and New Zealand demonstrate real success in managing the COVID-19 pandemic.

Data from the Australian and New Zealand registry ANZCTR.org.au shows there were 95 new trials registered in the past 30 days.

Avance Clinical is a medium-sized full-service CRO kn...